Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia. [electronic resource]
Producer: 20120224Description: 1619-26 p. digitalISSN:- 1592-8721
- Acute Disease
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzoquinones -- administration & dosage
- Checkpoint Kinase 1
- Cytarabine -- administration & dosage
- Female
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Lactams, Macrocyclic -- administration & dosage
- Leukemia -- drug therapy
- Male
- Middle Aged
- Protein Kinases -- metabolism
- Recurrence
- Time Factors
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.